Immunomedics, Inc.

NASDAQ: IMMU
$13.57
+$0.73 (+5.7%)
Real time price as of March 30, 2020 2:31 pm EDT
Immunomedics shares made a handy gain on Thursday after the company announced that the FDA has accepted its Biologics License Application for its breast cancer treatment.
Chris Lange
Here are five health-care-related stocks that recently saw their 50-day moving average cross above the 200-day average, a golden cross.
Trey Thoelcke
Immunomedics shares dropped sharply on Monday after the firm presented interim data from its midstage bladder cancer study at the European Society for Medical Oncology (ESMO) Annual Congress in...
Chris Lange
The top analyst upgrades, downgrades and initiations seen on Monday included Alector, Bed Bath & Beyond, Dillard's, Foot Locker, Hasbro, Kraft Heinz, Vale, Xilinx and Zoetis.
Jon C. Ogg
Immunomedics, Signet Jewelry, Nautilus, and Lexicon Pharmaceuticals had all posted new 52-week lows by noon Friday.
Paul Ausick
Immunomedics shares were crushed on Friday after the firm received disappointing news from the FDA on its breast cancer treatment.
Chris Lange
The top analyst upgrades, downgrades and other research calls from Monday include Ctrip.com, Goldman Sachs, Johnson & Johnson, Medtronic, Morgan Stanley, Yelp and Yum China.
Jon C. Ogg
Here are four biotech stocks for which the team of analysts at Jefferies, and analysts at other firms, see big upside potential from upcoming near-term drug study catalysts.
Jon C. Ogg
Immunomedics watched its shares make a massive gain on Friday after the company announced the termination of its licensing deal with Seattle Genetics.
Chris Lange
The health care sector was in trouble over the past year, under fire from congressional hearings and politicians on the campaign trail. At first 2017 seemed like it could be different for this...
Chris Lange
In the week of October 7, there were multiple analyst calls for stocks to buy that were trading under $10 per share, including Petrobras and Brocade Communications.
Jon C. Ogg
The late-summer doldrums are over and the markets are on the move again as we are now in the fourth quarter. But a few companies held the market back from pushing even higher.
Chris Lange
The top analyst upgrades, downgrades and initiations seen on Thursday morning include American Express, Encana, Petrobras, Raytheon, Tesla and Walgreens.
Jon C. Ogg
Shares of Immunomedics dropped sharply on Wednesday after the company announced the pricing of its secondary offering.
Chris Lange
Biotech companies that lost their way last week truly burned shareholders, whether it was due to ASCO, earnings or even unfavorable clinical trial updates.
Chris Lange